𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites

✍ Scribed by Kristina R. Dahlstrom; Guojun Li; Guillermo Tortolero-Luna; Qingyi Wei; Erich M. Sturgis

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
107 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

An emerging epidemic of human papillomavirus (HPV)‐associated oropharyngeal cancer has been proposed. The purpose of this study was for us to compare the sexual behaviors of patients with squamous cell carcinoma of the oropharynx (SCCOP) and patients with squamous cell carcinoma of non‐oropharyngeal (SCCNOP) head and neck sites to expand our understanding of sexual behavior as a risk factor for HPV‐associated head and neck cancer.

Methods.

The sexual history of 165 patients with SCCOP and 87 patients with SCCNOP was determined in a hospital‐based case‐to‐case comparison study.

Results.

Patients with SCCOP were significantly more likely than patients with SCCNOP to have had >9 lifetime sex partners (odds ratio [OR], 39.2; 95% confidence interval [CI], 8.2–187.3), to have engaged in oral‐genital sex (OR, 3.5; 95% CI, 1.1–11.1), and to have had >4 oral‐genital sex partners (OR, 8.6; 95% CI, 2.2–33.4).

Conclusion.

The findings of this study suggest that some risk factors are site‐specific and provide further evidence that certain sexual behaviors increase the risk of HPV‐associated SCCOP. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

📜 SIMILAR VOLUMES

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Radioimmunotherapy in patients with head
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
✍ David R. Colnot; Jasper J. Quak; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## Background Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, i

Immunoglobulin allotypes in patients wit
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant

Survival in patients with recurrent squa
Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy
✍ Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results